The Supreme Court will hear arguments Monday in a case that could fundamentally reshape how consumers pursue damages against pesticide makers, with the glyphosate wars serving as the flashpoint.
At stake is whether companies can escape liability for failing to warn of health risks when federal regulators haven't officially declared those risks exist. Monsanto, now owned by German conglomerate Bayer, is asking the Court to rule that the Federal Insecticide, Fungicide, and Rodenticide Act shields it from lawsuits over cancer warnings if the EPA hasn't determined glyphosate is carcinogenic.
The herbicide chemical, which powers Roundup and countless other weedkillers, has been linked to cancer in multiple scientific studies and was classified as a probable human carcinogen by a World Health Organization arm in 2015. Yet the EPA maintains glyphosate is "unlikely" to cause cancer. Monsanto has spent the last decade battling more than 100,000 lawsuits from people claiming the company failed to warn them of the risks.
Syngenta, a Chinese-owned manufacturer facing thousands of similar claims over its paraquat herbicide and links to Parkinson's disease, is backing Monsanto's legal challenge. A favorable ruling could protect not just these two companies but potentially insulate the entire pesticide industry from state-level warning requirements, legal experts say.
Monsanto's supporters argue that excessive warnings confuse consumers about which dangers truly matter. Lawrence Ebner, general counsel for the Atlantic Legal Foundation backing the company, framed the issue in stark terms: "If you have a pesticide label with a zillion different warnings, how is the user supposed to know the ones that really matter, the ones that EPA really has determined are necessary?"
The counterargument centers on federalism and public health. Former EPA official Jim Jones, who led the agency's chemical safety division under President Obama, joined other ex-EPA leaders in filing a brief opposing Monsanto's position. States, Jones argues, have a legitimate and necessary role in regulating pesticides and deciding what warnings consumers deserve. "It's the perspective I've held throughout my career at EPA. I think it is the correct one," he said.
The case has exposed an unusual split within Trump's political orbit. The administration's solicitor general will argue in Monsanto's favor at the courthouse Monday, while a grassroots rally organized by the "Make America Healthy Again" movement has been planned to protest outside. Trump issued an executive order in February aimed at protecting glyphosate production, yet his movement's own supporters view the case as a corporate power grab.
Vani Hari, a prominent health advocate and rally organizer, called out the contradiction directly: "The Trump administration should know that siding with Bayer over American families is a losing position. People expect leadership that puts their health first, not policies that protect corporations from being held responsible."
Author James Rodriguez: "This case will decide whether federal agencies get the final word on product dangers or whether states and juries can still demand better warnings, and that tension between corporate convenience and consumer choice rarely gets resolved cleanly."
Comments